Small business failure risk in Australia outpaces sector growth
Small business failure risk in Australia is increasing at a faster rate than the pace of overall business…
Patient groups cheer as the WHO adds diabetes and cystic fibrosis drugs to its essential medicines list
For the first time, the World Health Organization has added various high-cost treatments for diabetes and cystic fibrosis…
Passive Smoke Exposure in Prepubescent Males Affects Lung Function in Children, Grandchildren
A new study has found that paternal prepubertal passive smoke exposure was associated with impaired lung function trajectories…
FDA finds Amneal Pharma used contaminated IV bags for sterile drug
In a startling failure of quality control, Amneal Pharmaceuticals relied on contaminated bags for a sterile injectable drug…
Statins should be available over the counter
Welcome to The Workup, a new First Opinion column from Vishal Khetpal. There’s a saying in medicine: Statins…
Targeting gut signaling protein may protect against alcohol-related liver damage
Alcohol-associated liver disease (ALD) is a major cause of liver transplantation and death worldwide, and its impact is…
MAHA loves dietary supplements. But that hasn’t led to gains in Washington — yet.
An avid consumer of dietary supplements, Health and Human Services Secretary Robert F. Kennedy Jr. has surrounded himself…
Rising Obesity Rates in Adolescents, Young Adults Tied to Major Health Complications
Ashwin Chetty Credit: Yale School of Medicine New research is shedding light on large portions of obesity-related complications…
Is a statin drug right for you? Researchers try to right-size the risk
It’s a math problem with life-and-death consequences. When a new and improved model for estimating the risk of…
Rocket Pharma’s shares soar after US FDA lets gene therapy trial resume
Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…
Novo Nordisk offers diabetes drug Ozempic for steep cash discount
A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie…
Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
First Breakthrough Therapy Designation in the U.S. for SystImmune and Bristol Myers Squibb’s Izalontamab brengitecan (Iza-bren) based on data…